Package Leaflet: Information for the User
Aminoplasmal B. Braun 5% Solution for Infusion
Amino Acids
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
Aminoplasmal B. Braun 5% is a solution that is administered through a small tube with a cannula that is inserted into a vein (intravenous infusion).
The solution contains amino acids, which are essential for the growth and recovery of the body.
You will receive this medicine if you are unable to eat normally and cannot be fed through a tube inserted into your stomach. This solution can be administered to adults, adolescents, and children over 2 years of age.
Do not use Aminoplasmal B. Braun 5%
Your doctor will also consider that solutions with amino acids should not normally be used:
Newborns, infants, and young children under 2 years
This solution should not be administered to newborns, infants, or young children under 2 years, as the composition of the solution does not adequately meet the special nutritional needs of this age group.
Warnings and precautions
Consult your doctor before you are given Aminoplasmal B. Braun 5%
Additional precautions taken by your doctor
If your body's water or mineral balance is disturbed, this disturbance should be corrected before you are given this medicine. Examples of this disturbance are simultaneous lack of water and minerals (hypotonic dehydration) or lack of sodium (hyponatremia) or potassium (hypokalemia).
Before and while you are receiving this medicine, your blood levels of minerals and sugar, water balance, acid-base balance, blood proteins, and kidney and liver function will be monitored. For this purpose, blood samples will be taken and your urine will be collected for analysis.
Usually, you will receive Aminoplasmal B. Braun 5% as part of an intravenous feeding regimen that also includes non-protein energy supplements (carbohydrate solutions, fat emulsions), essential fatty acids, electrolytes, as well as vitamins, fluids, and trace elements.
If you are given this medicine in a small vein (peripheral vein), the infusion site will be checked daily for signs of irritation or inflammation of the vein (thrombophlebitis).
Using Aminoplasmal B. Braun 5% with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
If you are pregnant, you will only receive this medicine if your doctor considers it necessary for your recovery. There are no data available on the use of this medicine in pregnant women.
Breastfeeding
At therapeutic doses of Aminoplasmal B. Braun 5%, no effects are expected in the newborn/child during breastfeeding. However, breastfeeding is not recommended if women need intravenous feeding at the same time.
Driving and using machines
This medicine is usually administered to immobile patients in a controlled environment (emergency treatment, acute treatment in a hospital or day care center). This excludes driving and using machines.
A healthcare professional will administer Aminoplasmal B. Braun 5% to you.
Your doctor will determine the amount of medicine you need and the duration of treatment.
The solution will be administered through a small plastic tube that will be inserted into a vein.
Patients with kidney or liver disease
The doses will be adjusted according to your individual needs if you have liver or kidney disease.
Duration of administration
This medicine can be used as long as you need to receive intravenous feeding.
If you have received more Aminoplasmal B. Braun 5% than you should
This is unlikely to happen, as your doctor will determine your daily doses. However, if you receive an overdose or if the solution flows too quickly, you may feel nauseous or vomit or have headaches. Additionally, your blood may contain too much ammonia (hyperammonemia) or you may lose amino acids in your urine. You may also have too much fluid in your body (hyperhydration), your mineral balance may be disturbed (electrolyte imbalance), and you may have fluid in your lungs (pulmonary edema). If this happens, the infusion should be interrupted and resumed after some time at a lower infusion rate.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These side effects are not specifically related to Aminoplasmal B. Braun 5%, but can occur with any type of intravenous feeding, especially at the start.
The following side effects may be serious. If you experience any of the following side effects, tell your doctor immediately and he will stop administering this medicine:
Frequency not known (cannot be estimated from the available data)
Other side effects:
Uncommon (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from the available data)
Reactions at the infusion site, including local pain, irritation, or inflammation of the vein (thrombophlebitis)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible that they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton. The expiry date refers to the last day of the month shown.
Store the vial in the outer packaging to protect it from light.
Do not store above 25°C.
Store the solution in a cool place, below 15°C, may cause the formation of crystals that can, however, be easily dissolved by gentle warming to 25°C until complete dissolution. Shake the container gently to ensure homogeneity.
Do not freeze.
The solution should only be used if the container closure is not damaged and the solution is clear.
After infusion, any remaining solution should not be stored for later use.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
The active substances are amino acids.
This medicine contains:
Amino acids: | in 1 ml | in 250 ml | in 500 ml | in 1,000 ml |
Isoleucine | 2.50 mg | 0.63 g | 1.25 g | 2.50 g |
Leucine | 4.45 mg | 1.11 g | 2.23 g | 4.45 g |
Lysine monohydrate | 1.56 mg | 0.39 g | 0.78 g | 1.56 g |
(equivalent to lysine) | (1.39 mg) | (0.35 g) | (0.70 g) | (1.39 g) |
Lysine acetate (equivalent to lysine) Methionine | 2.87 mg (2.03 mg) 2.20 mg | 0.72 g (0.51g) 0.55 g | 1.44 g (1.02g) 1.10 g | 2.87 g (2.03g) 2.20 g |
Phenylalanine | 2.35 mg | 0.59 g | 1.18 g | 2.35 g |
Threonine | 2.10 mg | 0.53 g | 1.05 g | 2.10 g |
Tryptophan | 0.80 mg | 0.20 g | 0.40 g | 0.80 g |
Valine | 3.10 mg | 0.78 g | 1.55 g | 3.10 g |
Arginine | 5.75 mg | 1.44 g | 2.88 g | 5.75 g |
Histidine | 1.50 mg | 0.38 g | 0.75 g | 1.50 g |
Alanine | 5.25 mg | 1.31 g | 2.63 g | 5.25 g |
Glycine | 6.00 mg | 1.50 g | 3.00 g | 6.00 g |
Aspartic acid | 2.80 mg | 0.70 g | 1.40 g | 2.80 g |
Glutamic acid | 3.60 mg | 0.90 g | 1.80 g | 3.60 g |
Proline | 2.75 mg | 0.69 g | 1.38 g | 2.75 g |
Serine | 1.15 mg | 0.29 g | 0.58 g | 1.15 g |
Tyrosine | 0.40 mg | 0.10 g | 0.20 g | 0.40 g |
The other ingredients are acetylcysteine, citric acid monohydrate (for pH adjustment), and water for injections.
Electrolyte concentrations: | |||
Acetates | 14 mmol/l | ||
Citrates | 1.00-2.0 mmol/l |
Total amino acids | 50 g/l | ||
Total nitrogen | 7.9 g/l | ||
Caloric value [kJ/l (kcal/l)] | 835 (200) | ||
Theoretical osmolality [mOsm/l] | 435 mOsm/l | ||
Acidity (titration pH 7.4) [mmol NaOH/l] | approx. 9 mmol/l | ||
pH: | 5.7 – 6.3 |
Appearance of the product and pack contents
Aminoplasmal B. Braun 5% is a clear, colorless to slightly straw-colored solution and does not contain particles.
The product is available in colorless glass vials of 250 ml, 500 ml, and 1,000 ml, closed with a rubber stopper.
The 250 ml and 500 ml vials are available in packs of 10. The 1,000 ml vials are available in packs of 6.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Holder and manufacturer
Carl-Braun-Straße 1
34212 Melsungen
Germany
Postal address:
34209 Melsungen, Germany
Phone: +49/5661/71-0
Fax: +49/5661/71-4567
You can request more information about this medicine from the local representative of the marketing authorization holder
Ctra. Terrassa, 121
08191 Rubí (Spain)
This medicine has been authorized in the Member States of the EEA under the following names:
France Aminoplasmal 8, solution for infusion
Germany Aminoplasmal B. Braun 5
Portugal Aminoplasmal B. Braun 5%
Spain Aminoplasmal B. Braun 5% solution for infusion
Date of last revision of this leaflet:02/2021
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
-------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Intravenous route.
Aminoplasmal B. Braun 5% can be administered through a central or peripheral vein.
Dosage
Adults and adolescents from 14 to 17years
Your doctor will determine the amount of solution you need each day.
The normal dose will be 20 – 40 ml per kg of your body weight per day. The solution will flow at a rate not exceeding 2 ml per kg of your body weight per hour.
Children from2 to13years
In the case of children, the doctor will carefully adjust the dose based on age, developmental status, and existing disease.
The amounts to be administered will be approximately:
From 2 to 4 years: 30 ml per kg of body weight per day
From 5 to 13 years: 20 ml per kg of body weight per day
For severely ill children, the amount to be administered may be higher (up to 60 ml per kg of body weight per day).
The solution will be administered at a rate not exceeding 2 ml per kg of body weight per hour.
In cases where the amino acid requirements are 1 g per kg of body weight per day or more, special attention should be paid to the limitations of fluid intake. In these situations, amino acid solutions with a higher amino acid content may need to be used to avoid fluid overload.
Renal Insufficiency
In patients with renal insufficiency, the dose should be carefully adjusted based on individual needs, the severity of organic impairment, and the type of renal replacement therapy established (hemodialysis, hemofiltration, etc.).
Hepatic Insufficiency
In patients with hepatic insufficiency, the dose should be carefully adjusted based on individual needs and the severity of organic impairment.
Handling Instructions
Use a sterile administration set for the infusion of Aminoplasmal B. Braun 5% solution for infusion.
If, as part of total parenteral nutrition, it is necessary to add other nutrients to this medication, such as carbohydrates, lipids, vitamins, electrolytes, and trace elements, the addition should be performed under strict aseptic conditions. Mix well after the inclusion of any additive. Aminoplasmal B. Braun 5% can only be mixed with other nutrients whose compatibility has been documented. Upon request, the manufacturer will provide compatibility data for different additives and the corresponding validity period of such mixtures.
Special Precautions for Storage
Do not use the product if the solution is not transparent or if the container or its cap is damaged.
Storing the solution in the cold, below 15°C, may cause the formation of crystals that can, however, be easily dissolved by gentle heating to 25°C until complete dissolution. Gently shake the container to ensure homogeneity. Single-use containers. Discard the container and any contents after use.
Validity Period after Mixing with Additives
Do not refrigerate.
From a microbiological point of view, unless the opening and mixing method prevents the risk of microbial contamination, the product should be used immediately. If it is not used immediately, the conditions and storage times during use are the responsibility of the user.
.
For complete information on this medication, consult the Summary of Product Characteristics or the technical data sheet.